NIP
Nicholas Investment Partners Portfolio holdings
AUM
$1.12B
This Quarter Return
+2.09%
1 Year Return
+50.66%
3 Year Return
+286.38%
5 Year Return
+525.06%
10 Year Return
+2,262.45%
AUM
$1.37B
AUM Growth
+$1.37B
(-14%)
Cap. Flow
-$174M
Cap. Flow
% of AUM
-12.73%
Top 10 Holdings %
Top 10 Hldgs %
17.96%
Holding
225
New
21
Increased
69
Reduced
53
Closed
28
Top Buys
| 1 |
Ginkgo Bioworks
DNA
|
$27.6M |
| 2 |
MaxCyte
MXCT
|
$12M |
| 3 |
The Beauty Health Co
SKIN
|
$10.3M |
| 4 |
EXE
Expand Energy Corporation Common Stock
EXE
|
$8.57M |
| 5 |
Alpha Teknova
TKNO
|
$7.75M |
Top Sells
| 1 |
Zai Lab
ZLAB
|
$25.1M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$22.5M |
| 3 |
Inspire Medical Systems
INSP
|
$21.2M |
| 4 |
10x Genomics
TXG
|
$21.1M |
| 5 |
Repligen
RGEN
|
$13.9M |
Sector Composition
| 1 | Healthcare | 35.81% |
| 2 | Technology | 14.81% |
| 3 | Financials | 9.02% |
| 4 | Industrials | 8.86% |
| 5 | Consumer Discretionary | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TLIS
76
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $6.18M | 0.45% | 989,090 -82,225 | -8% | -$514K |
|
|
CELL
77
DELISTED
PhenomeX Inc. Common Stock
CELL
| $6.12M | 0.45% | 312,824 -145,552 | -32% | -$2.85M |
|
78
Lam Research
LRCX
$127B
| $6.05M | 0.44% | 10,634 +54 | +0.5% | +$30.7K |
|
79
Amazon
AMZN
$2.44T
| $6.02M | 0.44% | 1,833 +1,517 | +480% | +$4.98M |
|
80
Descartes Systems
DSGX
$8.57B
| $5.84M | 0.43% | 71,910 +2,316 | +3% | +$188K |
|
|
XYZ
81
Block, Inc.
XYZ
$48.5B
| $5.75M | 0.42% | 23,984 +674 | +3% | +$162K |
|
82
ASML
ASML
$292B
| $5.75M | 0.42% | 7,714 +261 | +4% | +$194K |
|
|
PACW
83
DELISTED
PacWest Bancorp
PACW
| $5.7M | 0.42% | 125,846 +5,738 | +5% | +$260K |
|
84
Microsoft
MSFT
$3.77T
| $5.38M | 0.39% | 19,090 +5,331 | +39% | +$1.5M |
|
85
Federal Signal
FSS
$7.48B
| $5.3M | 0.39% | 137,156 +33,165 | +32% | +$1.28M |
|
86
Twilio
TWLO
$16.2B
| $5.19M | 0.38% | 16,251 -3,428 | -17% | -$1.09M |
|
87
Werewolf Therapeutics
HOWL
$59.9M
| $5.08M | 0.37% | 296,283 +1,629 | +0.6% | +$28K |
|
88
JPMorgan Chase
JPM
$829B
| $4.91M | 0.36% | +30,000 | New | +$4.91M |
|
|
UMH
89
UMH Properties
UMH
$1.33B
| $4.78M | 0.35% | +208,720 | New | +$4.78M |
|
90
Apollo Global Management
APO
$77.9B
| $4.62M | 0.34% | 75,000 | – | – |
|
91
Light & Wonder
LNW
$7.76B
| $4.47M | 0.33% | +53,808 | New | +$4.47M |
|
92
Ascendis Pharma
ASND
$11.8B
| $4.33M | 0.32% | +27,134 | New | +$4.33M |
|
93
Match Group
MTCH
$8.98B
| $4.22M | 0.31% | 26,903 +775 | +3% | +$122K |
|
94
Prudential Financial
PRU
$38.6B
| $4.21M | 0.31% | 40,000 | – | – |
|
95
TSMC
TSM
$1.2T
| $4.19M | 0.31% | 37,496 +1,250 | +3% | +$140K |
|
96
Verra Mobility
VRRM
$3.96B
| $4.08M | 0.3% | 270,568 +74,116 | +38% | +$1.12M |
|
|
SI
97
DELISTED
Silvergate Capital Corporation
SI
| $4.02M | 0.29% | +34,770 | New | +$4.02M |
|
98
American Financial Group
AFG
$11.3B
| $3.95M | 0.29% | 31,370 -27,977 | -47% | -$3.52M |
|
99
SPDR S&P Biotech ETF
XBI
$5.07B
| $3.93M | 0.29% | +31,247 | New | +$3.93M |
|
100
CoStar Group
CSGP
$37.9B
| $3.91M | 0.29% | 45,483 +12,923 | +40% | +$1.11M |
|